Effectivity and Safety Study of Trans-artificial-urethral Resection of Female Urethral Caruncle

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02490228

Enrollment

100

Registered

2015-07-03

Start date

2015-07-31

Completion date

Unknown

Last updated

2015-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urethral Caruncle

Keywords

female, minimally invasive surgery

Brief summary

To explore the minimally invasive and exhaustive treatment of female urethral canruncle by using trans-artificial-urethral resection of the canruncle. The investigators plant to recruit patients using this surgical method and study the effectivity of this method.

Interventions

PROCEDURETAURFUC

female patients with urethral caruncle will receive transurethral resection combine with extension tube.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

\- patient with urethral caruncle

Exclusion criteria

\- recurrence urethral caruncle

Design outcomes

Primary

Measure	Time frame
Operative time	Up to 6 months
Length of hospital stay	Up to 6 months
Estimated blood loss	Up to 6 months
pathological type	Up to 6 months
Complication incidence rate	Up to 6 months

Secondary

Measure	Time frame
recurrence-free survival	Up to 12 months

Contacts

Primary ContactXuesong Li, MD

pineneedle@sina.com+86-10-83575101

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026